ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Csl Ltd (QX)

Csl Ltd (QX) (CSLLY)

16,62
0,27
( 1,65% )
Aktualisiert: 16:10:43

Csl Ltd (QX) (CSLLY) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
16,62
( 1,65% )
Gebot
16,59
Fragen
16,62
Volumen
34.644
16,55 Tagesbereich 16,65
16,29 52-Wochen-Bereich 89,71
Marktkapitalisierung
Handelsende
16,35
Handelsbeginn
16,55
Letzte Trade
100
@
16.62
Letzter Handelszeitpunkt
16:13:11
Finanzvolumen
US$ 575.210
VWAP
16,6035
Durchschnittliches Volumen (3 Mio.)
US$ 1.609.298
Ausgegebene Aktien
482.130.812
Dividendenrendite (LTM)
2,92
Kurs-Gewinn-Verhältnis
24,29
Gewinn pro Aktie (EPS)
2,86
Erlöse (LTM)
15,41B
Nettogewinn (LTM)
1,4B

Über Csl Ltd (QX)

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, ... CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Melbourne, Australia
Gegründet
2026
Csl Ltd (QX) is listed in the Healthcare sector of the OTC Markets with ticker CSLLY. The last closing price for Csl (QX) was US$16,35. Over the last year, Csl (QX) shares have traded in a share price range of US$ 16,29 to US$ 89,71.

Csl (QX) currently has 482.130.812 shares in issue. The market capitalisation of Csl (QX) is US$8,01 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 24.29.

CSLLY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.049-5.9369517233617.66917.66916.2987650617.14089356DR
4-5.39-24.48886869622.0122.2816.2960079917.75014734DR
12-8.29-33.279807306324.9126.6116.2953740621.8397678DR
26-42.34-71.811397557758.9667.063216.2935488029.66330582DR
52-63.13-79.159874608279.7589.7116.2923784039.76368593DR
156-86.405-83.8679932055103.02510916.2912868557.67798277DR
260-95.6117-85.1913496811112.2317117.4916.299915666.78005811DR

CSLLY - Frequently Asked Questions (FAQ)

What is the current Csl Ltd (QX) share price?
The current share price of Csl Ltd (QX) is US$ 16,62
How many Csl Ltd (QX) shares are in issue?
Csl Ltd (QX) has 482.130.812 shares in issue
What is the market cap of Csl Ltd (QX)?
The market capitalisation of Csl Ltd (QX) is USD 8,01B
What is the 1 year trading range for Csl Ltd (QX) share price?
Csl Ltd (QX) has traded in the range of US$ 16,29 to US$ 89,71 during the past year
What is the PE ratio of Csl Ltd (QX)?
The price to earnings ratio of Csl Ltd (QX) is 24,29
What is the cash to sales ratio of Csl Ltd (QX)?
The cash to sales ratio of Csl Ltd (QX) is 2,19
What is the registered address of Csl Ltd (QX)?
The registered address for Csl Ltd (QX) is 655 Elizabeth Street, Melbourne, Victoria, 3000
What is the Csl Ltd (QX) website address?
The website address for Csl Ltd (QX) is www.csl.com
Which industry sector does Csl Ltd (QX) operate in?
Csl Ltd (QX) operates in the Biotechnology & Life Sciences sector

CSLLY Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen